tetano
Editor, Senior Moderator
Front Immunol
. 2020 Sep 25;11:570919.
doi: 10.3389/fimmu.2020.570919. eCollection 2020.
Perspective: The Potential Effects of Naringenin in COVID-19
Ricardo Wesley Alberca[SUP] 1 [/SUP], Franciane Mouradian Emidio Teixeira[SUP] 2 [/SUP], Danielle Rosa Beserra[SUP] 1 [/SUP], Emily Araujo de Oliveira[SUP] 1 [/SUP], Milena Mary de Souza Andrade[SUP] 1 [/SUP], Anna Julia Pietrobon[SUP] 2 [/SUP], Maria Notomi Sato[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was declared a pandemic by the World Health Organization in March 2020. Severe COVID-19 cases develop severe acute respiratory syndrome, which can result in multiple organ failure, sepsis, and death. The higher risk group includes the elderly and subjects with pre-existing chronic illnesses such as obesity, hypertension, and diabetes. To date, no specific treatment or vaccine is available for COVID-19. Among many compounds, naringenin (NAR) a flavonoid present in citrus fruits has been investigated for antiviral and anti-inflammatory properties like reducing viral replication and cytokine production. In this perspective, we summarize NAR potential anti-inflammatory role in COVID-19 associated risk factors and SARS-CoV-2 infection.
Keywords: ACE2; COVID-19; SARS-CoV-2; TNF; anti-inflammatory; antiviral; naringenin.
. 2020 Sep 25;11:570919.
doi: 10.3389/fimmu.2020.570919. eCollection 2020.
Perspective: The Potential Effects of Naringenin in COVID-19
Ricardo Wesley Alberca[SUP] 1 [/SUP], Franciane Mouradian Emidio Teixeira[SUP] 2 [/SUP], Danielle Rosa Beserra[SUP] 1 [/SUP], Emily Araujo de Oliveira[SUP] 1 [/SUP], Milena Mary de Souza Andrade[SUP] 1 [/SUP], Anna Julia Pietrobon[SUP] 2 [/SUP], Maria Notomi Sato[SUP] 1 [/SUP]
Affiliations
- PMID: 33101291
- PMCID: PMC7546806
- DOI: 10.3389/fimmu.2020.570919
Abstract
Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was declared a pandemic by the World Health Organization in March 2020. Severe COVID-19 cases develop severe acute respiratory syndrome, which can result in multiple organ failure, sepsis, and death. The higher risk group includes the elderly and subjects with pre-existing chronic illnesses such as obesity, hypertension, and diabetes. To date, no specific treatment or vaccine is available for COVID-19. Among many compounds, naringenin (NAR) a flavonoid present in citrus fruits has been investigated for antiviral and anti-inflammatory properties like reducing viral replication and cytokine production. In this perspective, we summarize NAR potential anti-inflammatory role in COVID-19 associated risk factors and SARS-CoV-2 infection.
Keywords: ACE2; COVID-19; SARS-CoV-2; TNF; anti-inflammatory; antiviral; naringenin.